The Cortical Asymmetry Index for Subtyping Dementia Patients

Overview

Journal Eur Radiol

Specialty Radiology

Date 2025 Feb 11

PMID 39934339

Authors

Agnes Perez-Millan

Uma Maria Lal-Trehan Estrada

Neus Falgas

Nuria Guillen

Sergi Borrego-Ecija

Jordi Junca-Parella

Beatriz Bosch

Adria Tort-Merino

Jordi Sarto

Josep Maria Auge

Anna Antonell

Nuria Bargallo

Raquel Ruiz-Garcia

Laura Naranjo

Mircea Balasa

Albert Llado

Roser Sala-Llonch

Raquel Sanchez-Valle

Affiliations

Soon will be listed here.

Abstract

Objectives: Frontotemporal dementia (FTD) usually shows more asymmetric atrophy patterns than Alzheimer's disease (AD). We aim to quantify this asymmetry to differentiate FTD, AD, and FTD subtypes.

Methods: We studied T1-MRI scans, including FTD (different phenotypes), AD, and healthy controls (CTR). We defined the Cortical Asymmetry Index (CAI) using measures based on a metric derived from information theory with the cortical thickness measures. Some participants had additional follow-up MRIs, cerebrospinal fluid (CSF), or plasma measures. We analysed differences at cross-sectional and longitudinal levels. We then clustered FTD and AD participants based on the CAI values and studied the patients' fluid biomarker characteristics within each cluster.

Results: A total of 101 FTD patients (64 ± 8 years, 53 men), 230 AD patients (65 ± 10 years, 84 men), and 173 CTR (59 ± 15 years, 67 men) were studied. CAI differentiated FTD, AD, and CTR. It also distinguished the semantic variant primary progressive aphasia (svPPA) from the other FTD phenotypes. In FTD, the CAI increased over time. The cluster analysis identified two subgroups within FTD, characterised by different neurofilament-light (NfL) levels, and two subgroups within AD, with different plasma glial fibrillary acidic protein (GFAP) levels. In AD, CAI correlated with GFAP and Mini-Mental State Examination (MMSE); in FTD, the CAI was associated with NfL levels.

Conclusions: The proposed method quantifies asymmetries previously described visually. The CAI could define clinically and biologically meaningful disease subgroups in the differential diagnosis of AD and FTD and its subtypes. CAI could also be of interest in tracking disease progression in FTD.

Key Points: Question There is a need to find quantitative metrics from MRI that can identify disease subgroups, and that could be useful for diagnosis and tracking. Findings We propose a Cortical Asymmetry Index that differentiates Alzheimer's disease (AD) from Frontotemporal dementia (FTD), distinguishes FTD subtypes, correlates with NFL and GFAP levels, and monitors FTD progression. Clinical relevance Our proposed index holds the potential to support clinical applications for diagnosis and disease tracking in AD and FTD, using a quantitative summary metric from MRI data. It also contributes to the understanding of these diseases.

References

Harris J, Thompson J, Gall C, Richardson A, Neary D, du Plessis D . Do NIA-AA criteria distinguish Alzheimer's disease from frontotemporal dementia?. Alzheimers Dement. 2014; 11(2):207-15. DOI: 10.1016/j.jalz.2014.04.516. View

Koedam E, Lauffer V, van der Vlies A, van der Flier W, Scheltens P, Pijnenburg Y . Early-versus late-onset Alzheimer's disease: more than age alone. J Alzheimers Dis. 2010; 19(4):1401-8. DOI: 10.3233/JAD-2010-1337. View

Mendez M, Karve S, Tassniyom K, Teng E, Shapira J . Clinicopathologic differences among patients with behavioral variant frontotemporal dementia. Neurology. 2013; 80(6):561-8. PMC: 3589292. DOI: 10.1212/WNL.0b013e3182815547. View

Kong X, Mathias S, Guadalupe T, Glahn D, Franke B, Crivello F . Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Proc Natl Acad Sci U S A. 2018; 115(22):E5154-E5163. PMC: 5984496. DOI: 10.1073/pnas.1718418115. View

Toga A, Thompson P . Mapping brain asymmetry. Nat Rev Neurosci. 2003; 4(1):37-48. DOI: 10.1038/nrn1009. View

Gordon E, Rohrer J, Fox N . Advances in neuroimaging in frontotemporal dementia. J Neurochem. 2016; 138 Suppl 1:193-210. DOI: 10.1111/jnc.13656. View

Rabinovici G, Miller B . Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010; 24(5):375-98. PMC: 2916644. DOI: 10.2165/11533100-000000000-00000. View

Seelaar H, Rohrer J, Pijnenburg Y, Fox N, Van Swieten J . Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry. 2010; 82(5):476-86. DOI: 10.1136/jnnp.2010.212225. View

Whitwell J . FTD spectrum: Neuroimaging across the FTD spectrum. Prog Mol Biol Transl Sci. 2019; 165:187-223. PMC: 7153045. DOI: 10.1016/bs.pmbts.2019.05.009. View

10.

Rohrer J, Rosen H . Neuroimaging in frontotemporal dementia. Int Rev Psychiatry. 2013; 25(2):221-9. DOI: 10.3109/09540261.2013.778822. View

11.

Thompson S, Patterson K, Hodges J . Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology. 2003; 61(9):1196-203. DOI: 10.1212/01.wnl.0000091868.28557.b8. View

12.

Gorno-Tempini M, Hillis A, Weintraub S, Kertesz A, Mendez M, Cappa S . Classification of primary progressive aphasia and its variants. Neurology. 2011; 76(11):1006-14. PMC: 3059138. DOI: 10.1212/WNL.0b013e31821103e6. View

13.

Rascovsky K, Hodges J, Knopman D, Mendez M, Kramer J, Neuhaus J . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134(Pt 9):2456-77. PMC: 3170532. DOI: 10.1093/brain/awr179. View

14.

Herzog N, Magoulas G . Brain Asymmetry Detection and Machine Learning Classification for Diagnosis of Early Dementia. Sensors (Basel). 2021; 21(3). PMC: 7865614. DOI: 10.3390/s21030778. View

15.

Guadalupe T, Mathias S, vanErp T, Whelan C, Zwiers M, Abe Y . Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging Behav. 2016; 11(5):1497-1514. PMC: 5540813. DOI: 10.1007/s11682-016-9629-z. View

16.

Douglas P, Gutman B, Anderson A, Larios C, Lawrence K, Narr K . Hemispheric brain asymmetry differences in youths with attention-deficit/hyperactivity disorder. Neuroimage Clin. 2018; 18:744-752. PMC: 5988460. DOI: 10.1016/j.nicl.2018.02.020. View

17.

Kong X, Boedhoe P, Abe Y, Alonso P, Ameis S, Arnold P . Mapping Cortical and Subcortical Asymmetry in Obsessive-Compulsive Disorder: Findings From the ENIGMA Consortium. Biol Psychiatry. 2019; 87(12):1022-1034. PMC: 7094802. DOI: 10.1016/j.biopsych.2019.04.022. View

18.

Maingault S, Tzourio-Mazoyer N, Mazoyer B, Crivello F . Regional correlations between cortical thickness and surface area asymmetries: A surface-based morphometry study of 250 adults. Neuropsychologia. 2016; 93(Pt B):350-364. DOI: 10.1016/j.neuropsychologia.2016.03.025. View

19.

Schijven D, Postema M, Fukunaga M, Matsumoto J, Miura K, de Zwarte S . Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium. Proc Natl Acad Sci U S A. 2023; 120(14):e2213880120. PMC: 10083554. DOI: 10.1073/pnas.2213880120. View

20.

Lal-Trehan Estrada U, Meeks G, Salazar-Marioni S, Scalzo F, Farooqui M, Vivanco-Suarez J . Quantification of infarct core signal using CT imaging in acute ischemic stroke. Neuroimage Clin. 2022; 34:102998. PMC: 8980621. DOI: 10.1016/j.nicl.2022.102998. View